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Immunity
PreviewsTh2 and iTreg cells and also have some
contribution to 5hmC modification in Th1
and Th17 cells. The importance of 5mC
oxidation in promoting cytokine produc-
tionmight be underestimated by Ichiyama
et al. in their study. Experiments using
Tet2 and Tet3 doubly deficient cells and/
or mice might give the answers to these
unsolved important questions.
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NLRP12 is an innate immune receptor whose regulation of NF-kB signaling in myeloid cells is critical in pre-
ventingmultiple auto-inflammatory diseases. In this issue of Immunity, Lukens et al. (2015) show that a similar
NLRP12-mediated mechanism is functionally important in T cells.Nucleotide-binding domain and leucine-
rich repeat containing receptors (NLRs)
are a class of intracellular pattern recogni-
tion receptors (PRRs) of the innate im-
mune system whose functions appear to
be multifaceted. Whereas other classes
of PRRs, such as Toll-like receptors
(TLRs) and RIG-I-like receptors (RLRs),
primarily detect microbial ligands that
are indicative of a pathogenic insult,
NLRs seem to be involved in a wider vari-
ety of cellular functions, including micro-
bial recognition, but also the surveillance
of cellular integrity and the regulation of
intracellular signaling pathways. Most
NLRs with known functions can be
grossly categorized into two groups. The
first one is capable, upon triggering by a
multitude of exogenous and endogenous
stimuli, of assembling amulti-protein com-
plex called the inflammasome,which func-
tions to recruit and activate caspase-1,
leading to the cleavage and activation of
pro-interleukin-1b (IL-1b) and IL-18 into
their secreted forms (Henao-Mejia et al.,2014). The second group regulates the
canonical and non-canonical arms of
NF-kB signaling, a pivotal immune-modu-
latory intracellular pathway. One promi-
nent member of the latter class of NLRs
is NLRP12, originally described in overex-
pression assays as a negative regulator of
NF-kB-induced cytokine production,
when NLRP12 was still called PYPAF7 or
Monarch-1 (Wang et al., 2002). With the
generation of Nlrp12/ mice came the
realization that this NLR and its down-
stream control of NF-kB are critical to pre-
vent a multitude of immune-mediated or
-modulated diseases, including allergic
contact hypersensitivity (Arthur et al.,
2010), colitis, and colorectal cancer (Allen
et al., 2012; Zaki et al., 2011).
As diverse as the cellular functions of
NLRs are the cell types inwhich they oper-
ate. Originally discovered to be mainly
expressed and operational in myeloid
cells, the spectrum of tissues and cell
types in which NLRs are at play has
recently been expanded to other cells ofthe immune system and eventually even
to non-hematopoietic cells (Elinav et al.,
2011). In this issue of Immunity, Lukens
et al. (2015) have shown that this
expanded cellular diversity also holds
true in regard to NLRP12. Early reports
show that NLRP12 plays a prominent
role in mononuclear phagocytes, where it
regulates NF-kB-induced pro-inflamma-
tory cytokine production to inhibit auto-
inflammation (Allen et al., 2012; Arthur
et al., 2010; Zaki et al., 2011). Lukens
et al. (2015) have now demonstrated that
the expression and function of NLRP12
is not limited to the myeloid system. By
using a series of expression studies,
adoptive transfers, and bone marrow
chimera experiments, Lukens et al. (2015)
have found a T cell-intrinsic role for
NLRP12 in regulating NF-kB signaling
and pro-inflammatory cytokine produc-
tion. Phenotypically, the absence of
NLRP12 in T cells manifested in higher
expression of activation markers, en-
hanced cell proliferation, and elevated42, April 21, 2015 ª2015 Elsevier Inc. 595
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Figure 1. NLRP12 Regulates NF-kB and Cytokine Responses in T Cells
Lukens et al. (2015) demonstrate that absence of NLRP12 leads to enhanced NF-kB signaling, hyperproliferation, and elevated cytokine secretion in T cells. This
results in the manifestation of auto-inflammatory disorders, including colitis, and in atypical experimental autoimmune encephalomyelitis (EAE).
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Previewssecretion of cytokines involved in type I
immunity (e.g., IFN-g), type II immunity
(IL-4), and type III immunity (IL-17). As a
consequence,mice adoptively transferred
with NLRP12-deficient T cells developed
enhanced inflammatory symptoms in dis-
ease models classically associated with
pro-inflammatory T cells, including colitis
and atopic dermatitis. Surprisingly, in
another prototypically T cell-driven dis-
ease model, experimental autoimmune
encephalomyelitis (EAE, themousemodel
for multiple sclerosis), NLRP12 deficiency
led to ameliorated, rather than enhanced,
disease severity. Interestingly, Lukens
et al. (2015) noted increased ataxia and
loss of balance in Nlrp12/ mice in this
model, indicative of the development of
atypical EAE. This NLPR12-dependent
switch from classical to atypical EAE was
mediated by IL-4, and when Lukens et al.
(2015) blocked IL-4 in Nlrp12/ mice,
autoimmunity persisted but the neuro-
logical phenotype was reverted back to a
more classical pathology (Figure 1).
The discovery of a T cell-intrinsic role of
a PRR is not without precedent. Despite596 Immunity 42, April 21, 2015 ª2015 Elsevthe fact that T cells are not classically
considered to be pathogen-sensing cells,
they express a variety of PRRs that are
functionally involved in the regulation of
immune responses. For instance, T cell-
intrinsic expression of TLR2 maintains
intestinal homeostasis by integrating sig-
nals derived from the intestinal microbiota
(Round et al., 2011). Like other PRRs,
NLRP12 might be potentially involved in
T cell sensing of endogenous or exoge-
nous signals. Of note, in myeloid cells,
NLRP12 has been implicated in the
sensing of the intracellular pathogen Yer-
sinia pestis, the causative agent of plague
(Vladimer et al., 2012). Whether T cells are
able to sense these or other ligands
through NLRP12, and whether such mi-
crobial or damage-related recognition is
involved in NLRP12-mediated regulation
of NF-kB and with initiation and propaga-
tion of inflammatory responses, remains
to be unraveled in future studies.
These remaining questions notwith-
standing, the study by Lukens et al.
(2015) represents an important step to-
ward better mechanistic understandingier Inc.of T cell-driven auto-inflammatory dis-
ease. Missense mutations in NLRP12
cause hereditary periodic fever syn-
dromes in humans (Je´ru et al., 2008),
and the finding by Lukens et al. (2015)
now calls for the systematic investigation
of whether dysregulation of T cell cytokine
signaling is causally involved in the devel-
opment of inflammatory symptoms in pa-
tients with mutated NLRP12. Further-
more, the study represents an exciting
starting point for further mechanistic
elucidation of conceptually important
questions related to the roles of NLRs in
cell-intrinsic innate instruction of adoptive
immunity. For instance, which subsets of
T cells express NLRP12? Is the cytokine
dysregulation specific to a particular set
of T helper (Th) cells? Is subset-specific
NLRP12 activity in Th1, Th2, and Th17
cell lineages differentially regulated in
different disease settings? Answering
these questions will be instrumental
to understanding the pathogenesis of
NLRP12-mediated inflammatory disor-
ders. Overall, the versatile functions of
NLRs and their often unexpected cellular
Immunity
Previewsdistributions do not cease to surprise the
scientific community, and it is plausible
that more cell types and functions are
soon to be joining the club.
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In the present issue of Immunity, Hoeffel et al. (2015) reconcile a controversy by demonstrating that a distinct
wave of yolk-sac-derived erythro-myeloid progenitors (EMPs) differentiate to fetal monocytes in the liver and
further to adult macrophages in the majority of tissues.Macrophages are evolutionarily ancient
innate immune cells that are found in
most tissues and organs and whose func-
tions are highly specialized to their spe-
cific environments. It has been generally
accepted that the majority of tissue-
resident macrophage subsets originate
during fetal hematopoiesis and are there-
after maintained by local self-renewal with
minimal contribution of bone marrow
(BM)-derived progenitors. However, the
hemogenic site of origin within the em-
bryo has remained a matter of intense
debate, with controversial experimental
evidence supporting both fetal liver-
derived and yolk-sac (YS)-derived pro-
genitors. In this issue of Immunity, Hoeffel
et al. (2015) show that the majority of he-
matopoietic stem cell (HSC)-independent
tissue-resident macrophages originate
from fetal monocytes, which arise from
a transient wave of YS-derived erythro-
myeloid progenitors (EMPs) that colonize
the fetal liver.For the past 4 decades, it has been
widely accepted that blood monocytes
derived from BM hematopoietic stem
cells (HSCs) differentiate to macrophages
upon tissue entry. However, over the past
4 years, a torrent of reports has over-
turned this dogma. These reports have
unequivocally demonstrated an embry-
onic origin for the vast majority of tissue-
resident macrophages, which thereafter
are maintained largely independently of
adult HSC-dependent hematopoiesis.
Exceptions include intestinal and dermal
macrophages that are mainly BM mono-
cyte derived (Ginhoux and Jung, 2014).
Fetal hematopoiesis occurs in distinct
‘‘waves,’’ but their differential contribu-
tions to embryonic and adult macrophage
populations and the identity of precursors
has remained poorly characterized. In
the last trimester before the emergence
of mature tissue macrophages, fetal
organs contain two potential myeloid
progenitor populations, F4/80hiCD11bloprimitive macrophages and F4/80int
CD11bhi fetal monocytes, which are pro-
posed to arise from the YS and fetal liver,
respectively (Schulz et al., 2012). Opin-
ions differ on the question of which of the
two are the precursors of the mature tis-
sue resident macrophages. Using fate-
mapping, recent reports conclude that
tissue macrophages are predominantly
of fetal monocyte origin (Epelman et al.,
2014; Hoeffel et al., 2012), with the excep-
tion of microglia that derive from early
brain-seeding YS-derived primitive mac-
rophages (Ginhoux et al., 2010). Consis-
tently, adoptive cell transfer studies reveal
a bona fide alveolar macrophage progen-
itor potential of fetal monocytes (Guilliams
et al., 2013; Schneider et al., 2014). How-
ever, Geissmann and colleagues have
provided a strong argument that tissue
macrophages are derived from primi-
tive YS-derived macrophages, based on
the presence of F4/80hiCD11blo macro-
phages in skin, spleen, pancreas, kidney,42, April 21, 2015 ª2015 Elsevier Inc. 597
